Multimodal mapping and monitoring is beneficial during awake craniotomy for intra-cranial tumours: results of a dual centre retrospective study.


Journal

British journal of neurosurgery
ISSN: 1360-046X
Titre abrégé: Br J Neurosurg
Pays: England
ID NLM: 8800054

Informations de publication

Date de publication:
Apr 2023
Historique:
pubmed: 18 12 2021
medline: 23 3 2023
entrez: 17 12 2021
Statut: ppublish

Résumé

The combination of awake craniotomy with multimodal neurophysiological mapping and monitoring in intra-axial tumour resection is not well described, but may have theoretical benefits which we sought to investigate. All patients undergoing awake craniotomy for tumour resection with cortical and/or subcortical stimulation together with one or more of electrocorticography (ECoG/EEG), motor or somatosensory evoked potentials were identified from the operative records of two surgeons at two centres over a 5 year period. Patient, operative and outcome data were collated. Statistical analysis was performed to evaluate factors predictive of intra-operative seizures and surgical outcomes. 83 patients with a median age 50 years (18-80 years) were included. 80% had gliomas (37% low grade) and 13% metastases. Cortical mapping was negative in 35% (language areas) and 24% (motor areas). Complete or near total resection was achieved in 80% with 5% severe long-term neurological deficits. Negative cortical mapping was combined with positive subcortical mapping in 42% with no significant difference in extent of resection rates to patients undergoing positive cortical mapping ( Awake multi-modal monitoring is a safe and well tolerated technique. It provides preservation of extent of resection and clinical outcomes in cases of aborted awake craniotomy. Negative cortical mapping in combination with positive subcortical mapping was also shown to be safe, although not hitherto well described. Electrocorticography further enables the differentiation of seizure activity from true positive mapping, and the successful treatment of spikes prior to full clinical seizures occurring.

Sections du résumé

BACKGROUND UNASSIGNED
The combination of awake craniotomy with multimodal neurophysiological mapping and monitoring in intra-axial tumour resection is not well described, but may have theoretical benefits which we sought to investigate.
METHODS UNASSIGNED
All patients undergoing awake craniotomy for tumour resection with cortical and/or subcortical stimulation together with one or more of electrocorticography (ECoG/EEG), motor or somatosensory evoked potentials were identified from the operative records of two surgeons at two centres over a 5 year period. Patient, operative and outcome data were collated. Statistical analysis was performed to evaluate factors predictive of intra-operative seizures and surgical outcomes.
RESULTS UNASSIGNED
83 patients with a median age 50 years (18-80 years) were included. 80% had gliomas (37% low grade) and 13% metastases. Cortical mapping was negative in 35% (language areas) and 24% (motor areas). Complete or near total resection was achieved in 80% with 5% severe long-term neurological deficits. Negative cortical mapping was combined with positive subcortical mapping in 42% with no significant difference in extent of resection rates to patients undergoing positive cortical mapping (
CONCLUSIONS UNASSIGNED
Awake multi-modal monitoring is a safe and well tolerated technique. It provides preservation of extent of resection and clinical outcomes in cases of aborted awake craniotomy. Negative cortical mapping in combination with positive subcortical mapping was also shown to be safe, although not hitherto well described. Electrocorticography further enables the differentiation of seizure activity from true positive mapping, and the successful treatment of spikes prior to full clinical seizures occurring.

Identifiants

pubmed: 34918613
doi: 10.1080/02688697.2021.2016622
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

182-187

Auteurs

James Manfield (J)

Department of Neurosurgery, Manchester Centre for Clinical Neurosciences (MCCN), Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Mueez Waqar (M)

Department of Neurosurgery, Manchester Centre for Clinical Neurosciences (MCCN), Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Deborah Mercer (D)

Department of Neurophysiology, MCCN, Salford Royal Hospital, Manchester, UK.

Sheeba Ehsan (S)

Department of Neurophysiology, MCCN, Salford Royal Hospital, Manchester, UK.

Jacki Bambrough (J)

Department of Neurophysiology, MCCN, Salford Royal Hospital, Manchester, UK.

Nadir Ibrahim (N)

Department of Anaesthesia, MCCN, Salford Royal Hospital, Manchester, UK.

Kris Sivarajan (K)

Department of Anaesthesia, MCCN, Salford Royal Hospital, Manchester, UK.

Matt Bailey (M)

Department of Neurosurgery, Manchester Centre for Clinical Neurosciences (MCCN), Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Konstantina Karabatsou (K)

Department of Neurosurgery, Manchester Centre for Clinical Neurosciences (MCCN), Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

David Coope (D)

Department of Neurosurgery, Manchester Centre for Clinical Neurosciences (MCCN), Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Athi Ponnusamy (A)

Department of Neurophysiology, MCCN, Salford Royal Hospital, Manchester, UK.

Isaac Phang (I)

Department of Neurosurgery, Royal Preston Hospital. Lancashire teaching Hospitals NHS Foundation Trust, Preston, UK.

Pietro Ivo D'Urso (PI)

Department of Neurosurgery, Manchester Centre for Clinical Neurosciences (MCCN), Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH